Top 3 Tips for Mainland Chinese Biotech Companies Listing on the HKEX

Earlier this year the Hong Kong Stock Exchange (HKEX) updated its listing regime to include biotech companies. To accommodate their unique status as an emerging industry, the HKEX does not require them to demonstrate a record of profitability, but a special advisory panel assesses each listing.

For biotech companies considering a public debut on the HKEX, here are three top tips to help ensure a successful IPO. To learn more about how Tricor can help your company throughout a listing process, please contact one of our experts.